149 related articles for article (PubMed ID: 37222944)
1. ASO Author Reflections: Use of Machine Learning to Predict Early Recurrence After Resection of Intrahepatic Cholangiocarcinoma.
Alaimo L; Pawlik TM
Ann Surg Oncol; 2023 Sep; 30(9):5416-5417. PubMed ID: 37222944
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Identification of Intrahepatic Cholangiocarcinoma Clusters Using Machine Learning Techniques: Should Patients be Treated Differently?
Tsilimigras DI; Paredes AZ; Pawlik TM
Ann Surg Oncol; 2020 Dec; 27(13):5233-5234. PubMed ID: 32591955
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: Monitoring the Risk of Recurrence After Curative-Intent Liver Resection for Intrahepatic Cholangiocarcinoma by Applying Hazard Function Analysis.
Alaimo L; Moazzam Z; Pawlik TM
Ann Surg Oncol; 2023 Mar; 30(3):1350-1351. PubMed ID: 36006495
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Intrahepatic Cholangiocarcinoma: Downstaging Strategies Open the Gate to Surgery and Cure.
Boudjema K; Edeline J
Ann Surg Oncol; 2020 Oct; 27(10):3738-3739. PubMed ID: 32314152
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Mini-Invasive Hilar Cholangiocarcinoma Resection: Could Robots Be the Key?
Camerlo A; Seux H
Ann Surg Oncol; 2022 Apr; 29(4):2408-2409. PubMed ID: 35006504
[No Abstract] [Full Text] [Related]
6. ASO Author Reflections: Accuracy of Preoperative Staging and Downstaging After Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma.
Alaimo L; Lima HA; Moazzam Z; Pawlik TM
Ann Surg Oncol; 2023 Aug; 30(8):4809-4810. PubMed ID: 37046130
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: Disparate Outcomes in Stage II Intrahepatic Cholangiocarcinoma: A Case for Upstaging Multifocal Tumors.
Turner KM; Wilson GC
Ann Surg Oncol; 2022 Aug; 29(8):5103-5104. PubMed ID: 35482267
[No Abstract] [Full Text] [Related]
8. ASO Author Reflections: Incorporating Circulating Tumor DNA in Perioperative Management of Intrahepatic Cholangiocarcinoma.
Choi WJ; Sapisochin G; O'Kane GM
Ann Surg Oncol; 2023 Jun; 30(6):3864-3865. PubMed ID: 36752965
[No Abstract] [Full Text] [Related]
9. ASO Author Reflections: A New Reliable Method of Evaluating Cancer-Associated Fibroblasts in Resected Specimen of Intrahepatic Cholangiocarcinoma.
Eguchi S; Yamada D; Kobayashi S; Sasaki K; Iwagami Y; Tomimaru Y; Noda T; Takahashi H; Asaoka T; Tanemura M; Doki Y; Eguchi H
Ann Surg Oncol; 2023 Sep; 30(9):5429-5430. PubMed ID: 37273026
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: Higher Tumor Burden Status Dictates the Impact of Surgical Margin Status in Patients with Intrahepatic Cholangiocarcinoma.
Endo Y; Moazzam Z; Lima HA; Pawlik TM
Ann Surg Oncol; 2023 Apr; 30(4):2033-2034. PubMed ID: 36396871
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Long-Term Outcomes and Optimal Margin Width Among Patients Undergoing Hepatectomy for Intrahepatic Cholangiocarcinoma.
Alaimo L; Moazzam Z; Pawlik TM
Ann Surg Oncol; 2023 Jul; 30(7):4302-4303. PubMed ID: 36964330
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Panoramic Histologic Patterns of Caudate Lobe Invasion in Hilar Cholangiocarcinoma.
Jiang N; Xiang CH; Wang SY; Jin S
Ann Surg Oncol; 2022 Oct; 29(11):6813-6814. PubMed ID: 35668308
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Is Systemic Immune-Inflammation Index a Useful Biomarker After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium.
Toyoda J; Sahara K; Endo I; Pawlik TM
Ann Surg Oncol; 2022 Nov; 29(12):7615-7616. PubMed ID: 35776259
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: Lymph Node Examination and Patterns of Nodal Metastasis of Left- Versus Right-Sided Intrahepatic Cholangiocarcinoma.
Zhang XF; Pawlik TM
Ann Surg Oncol; 2023 Mar; 30(3):1434-1435. PubMed ID: 36380253
[No Abstract] [Full Text] [Related]
15. ASO Author Reflections: Radiomics-Based Strategy of Combining Conventional Clinico-Radiological Characteristics with Preoperative Prediction of Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma.
Li J; Huang S; Zhang S; Tian J; Shen F
Ann Surg Oncol; 2022 Oct; 29(11):6800-6801. PubMed ID: 35780454
[No Abstract] [Full Text] [Related]
16. ASO Author Reflections: Impact of Tumor Necrosis on Prognosis of Patients Undergoing Resection for T1 Intrahepatic Cholangiocarcinoma.
Tsilimigras DI; Pawlik TM
Ann Surg Oncol; 2022 May; 29(5):2975-2976. PubMed ID: 35217976
[No Abstract] [Full Text] [Related]
17. ASO Author Reflections: Classification of Intrahepatic Cholangiocarcinoma into Perihilar versus Peripheral Subtype.
Wei T; Zhang XF; Pawlik TM
Ann Surg Oncol; 2024 Feb; 31(2):1274-1275. PubMed ID: 37993744
[No Abstract] [Full Text] [Related]
18. ASO Author Reflections: Robotic Perihilar Cholangiocarcinoma Beyond Technical Feasibility.
Di Benedetto F; Magistri P; Di Sandro S
Ann Surg Oncol; 2023 May; 30(5):2834-2835. PubMed ID: 36840859
[No Abstract] [Full Text] [Related]
19. Machine learning radiomics can predict early liver recurrence after resection of intrahepatic cholangiocarcinoma.
Jolissaint JS; Wang T; Soares KC; Chou JF; Gönen M; Pak LM; Boerner T; Do RKG; Balachandran VP; D'Angelica MI; Drebin JA; Kingham TP; Wei AC; Jarnagin WR; Chakraborty J
HPB (Oxford); 2022 Aug; 24(8):1341-1350. PubMed ID: 35283010
[TBL] [Abstract][Full Text] [Related]
20. Intrahepatic cholangiocarcinoma: a worthy challenge.
Bartlett DL
Cancer J; 2009; 15(3):255-6. PubMed ID: 19556913
[No Abstract] [Full Text] [Related]
[Next] [New Search]
